Back to search
FDAFDA · Food and drugs·Recall number D-0063-2020

Hydroxocobalamin 30 mg/30 mL (1 mg/mL) 30 mL Vial For IM Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678334

Published October 9, 2019 · Recall initiated: September 12, 2019

Summary

FDA records drug Class II recall D-0063-2020, published October 9, 2019 and initiated September 12, 2019. Recalling firm: KRS Global Biotechnology, Inc; Status: Terminated; Reported quantity: 345 vials; Lot: All lots remaining within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
KRS Global Biotechnology, Inc
Distributor
Nationwide
Lot
All lots remaining within expiry.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydroxocobalamin 30 mg/30 mL (1 mg/mL) 30 mL Vial For IM Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678334 recalled?

Yes. FDA published recall D-0063-2020 on October 9, 2019. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Press Release